McKesson cleared to acquire Rexall Health

SAN FRANCISCO  — McKesson on Wednesday announced that it has signed a consent agreement with the Competition Bureau of Canada allowing it to proceed with the acquisition of Rexall Health (inclusive of Rexall/Pharma Plus, Medicentres Canada and Claimsecure). McKesson expects to close the transaction as expeditiously as possible subject to certain closing conditions.



“We are pleased to have received regulatory approval from the Competition Bureau of Canada,” stated Paul Julian, EVP and group president, McKesson Corporation. “Together, McKesson and Rexall Health will continue to deliver choice and access, integrated pharmacy care and industry-leading service levels.”



When conducting its review of McKesson’s acquisition of Rexall Health, the Competition Bureau of Canada identified 26 local markets where McKesson is required to divest Rexall stores to new owners.



McKesson does not anticipate any store closures as a result of these divestitures.